Chester County News and Community Website
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), headquartered in West Chester, PA, is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. For more information, visit www.verrica.com.
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced U.S. Food and Drug Administration (FDA) approval of YCANTH™ (cantharidin) topical solution for the treatment of molluscum contagiosum (molluscum) in …
Verrica Pharmaceuticals Announces FDA Approval of YCANTH™ (cantharidin) Topical Solution Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, announced that Ted White, Verrica President & Chief Executive Officer, will present at the upcoming Jefferies Healthcare …
Verrica Pharmaceuticals Announces Presentation at the Jefferies Healthcare Conference in New York Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that Ted White, Verrica President & Chief Executive Officer, will present at the upcoming RBC Capital Markets Global Healthcare Conference, …
Verrica Pharmaceuticals Announces Presentation at the RBC Capital Markets Global Healthcare Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company, announced financial results for the first quarter ended March 31, 2023.
Verrica Pharmaceuticals Reports First Quarter 2023 Financial Results Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) recently announced that the first patient has been dosed in Part 2 of a Phase 2 study evaluating the Company’s potentially …
Verrica Pharmaceuticals Announces Dosing of the First Patient in Part 2 of Phase 2 Study Evaluating VP-315 Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced Ted White, Verrica President and CEO, will present at the 22nd Annual Needham Virtual Healthcare Conference, which is being held from …
Verrica Pharmaceuticals Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) this week announced financial results for the fourth quarter and year ended December 31, 2022.
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that the U.S. Food and Drug Administration (FDA) accepted for filing the Company’s resubmitted New Drug Application (NDA) for VP-102 …
Verrica Pharmaceuticals Announces FDA Status Update of VP-102 Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) recently announced the pricing of its underwritten offering of 750,000 shares of its common stock and pre-funded warrants to purchase 4,064,814 …
Verrica Announces Pricing of $32.5 Million Underwritten Offering of Common Stock and Pre-Funded Warrants Read More